
Hua Qi
Examiner (ID: 389, Phone: (571)272-3193 , Office: P/1714 )
| Most Active Art Unit | 1714 |
| Art Unit(s) | 4142, 1714 |
| Total Applications | 636 |
| Issued Applications | 291 |
| Pending Applications | 93 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9910225
[patent_doc_number] => 20150065427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'MODULATION OF OSTEOCLAST DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 14/484646
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6249
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484646
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/484646 | MODULATION OF OSTEOCLAST DIFFERENTIATION | Sep 11, 2014 | Abandoned |
Array
(
[id] => 9910223
[patent_doc_number] => 20150065425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'PRODUCTS COMPRISING AN EXTRACELLULAR MATRIX MATERIAL AND OSTEOGENIC PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/474722
[patent_app_country] => US
[patent_app_date] => 2014-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9155
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14474722
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/474722 | PRODUCTS COMPRISING AN EXTRACELLULAR MATRIX MATERIAL AND OSTEOGENIC PROTEIN | Sep 1, 2014 | Abandoned |
Array
(
[id] => 11324971
[patent_doc_number] => 20160355584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS'
[patent_app_type] => utility
[patent_app_number] => 14/913578
[patent_app_country] => US
[patent_app_date] => 2014-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47015
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913578
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913578 | Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics | Aug 31, 2014 | Issued |
Array
(
[id] => 9908933
[patent_doc_number] => 20150064134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES, CONDITIONS, OR PROCESSES CHARACTERIZED BY ABERRANT FIBROBLAST PROLIFERATION AND EXTRACELLULAR MATRIX DEPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/473339
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 66619
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473339
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/473339 | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition | Aug 28, 2014 | Issued |
Array
(
[id] => 10960411
[patent_doc_number] => 20140363439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'ANTI-LRP6 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/466794
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 42006
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14466794
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/466794 | Anti-LRP6 antibodies | Aug 21, 2014 | Issued |
Array
(
[id] => 9838575
[patent_doc_number] => 20150030656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis'
[patent_app_type] => utility
[patent_app_number] => 14/452304
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10301
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452304
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/452304 | Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis | Aug 4, 2014 | Issued |
Array
(
[id] => 10247358
[patent_doc_number] => 20150132354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'TISSUE SCAFFOLDS HAVING BONE GROWTH FACTORS'
[patent_app_type] => utility
[patent_app_number] => 14/452422
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14849
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452422
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/452422 | Tissue scaffolds having bone growth factors | Aug 4, 2014 | Issued |
Array
(
[id] => 9813556
[patent_doc_number] => 20150025501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'Composition and Method for the Treatment or Prevention of Spinal Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/339037
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 45101
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14339037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/339037 | Composition and method for the treatment or prevention of spinal disorders | Jul 22, 2014 | Issued |
Array
(
[id] => 10968117
[patent_doc_number] => 20140371151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'Use of Liposomal WNT Composition to Enhance Osseointegration'
[patent_app_type] => utility
[patent_app_number] => 14/337718
[patent_app_country] => US
[patent_app_date] => 2014-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11905
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14337718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/337718 | Use of liposomal WNT composition to enhance osseointegration | Jul 21, 2014 | Issued |
Array
(
[id] => 13968295
[patent_doc_number] => 10213481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Compositions and methods to treat inflammatory joint disease
[patent_app_type] => utility
[patent_app_number] => 14/902502
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 8866
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/902502 | Compositions and methods to treat inflammatory joint disease | Jul 1, 2014 | Issued |
Array
(
[id] => 9805237
[patent_doc_number] => 20150017182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING AN IL-4R ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 14/310419
[patent_app_country] => US
[patent_app_date] => 2014-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27252
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14310419
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/310419 | Methods for treating nasal polyposis by administering an IL-4R antagonist | Jun 19, 2014 | Issued |
Array
(
[id] => 9736022
[patent_doc_number] => 20140271735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'USE OF CALCITONIN IN OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 14/293459
[patent_app_country] => US
[patent_app_date] => 2014-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9627
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14293459
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/293459 | USE OF CALCITONIN IN OSTEOARTHRITIS | Jun 1, 2014 | Abandoned |
Array
(
[id] => 9917731
[patent_doc_number] => 20150072936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'METHODS FOR PROMOTING WOUND HEALING AND/OR REDUCING SCAR FORMATION'
[patent_app_type] => utility
[patent_app_number] => 14/284210
[patent_app_country] => US
[patent_app_date] => 2014-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8431
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14284210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/284210 | METHODS FOR PROMOTING WOUND HEALING AND/OR REDUCING SCAR FORMATION | May 20, 2014 | Abandoned |
Array
(
[id] => 9657535
[patent_doc_number] => 20140228540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/259064
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21322
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/259064 | POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS | Apr 21, 2014 | Abandoned |
Array
(
[id] => 10705481
[patent_doc_number] => 20160051629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'INHIBITION OF RIP KINASES FOR TREATING LYSOSOMAL STORAGE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/781316
[patent_app_country] => US
[patent_app_date] => 2014-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12973
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781316
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781316 | INHIBITION OF RIP KINASES FOR TREATING LYSOSOMAL STORAGE DISEASES | Apr 8, 2014 | Abandoned |
Array
(
[id] => 10670901
[patent_doc_number] => 20160017046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OSTEOLYTIC BONE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/770752
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10791
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770752
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770752 | COMPOSITIONS AND METHODS FOR TREATING OSTEOLYTIC BONE DISORDERS | Mar 27, 2014 | Abandoned |
Array
(
[id] => 10939955
[patent_doc_number] => 20140342976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR MINIMALLY-INVASIVE SYSTEMIC DELIVERY OF PROTEINS INCLUDING TGF-BETA SUPERFAMILY MEMBERS'
[patent_app_type] => utility
[patent_app_number] => 14/215232
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13064
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14215232
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/215232 | COMPOSITIONS AND METHODS FOR MINIMALLY-INVASIVE SYSTEMIC DELIVERY OF PROTEINS INCLUDING TGF-BETA SUPERFAMILY MEMBERS | Mar 16, 2014 | Abandoned |
Array
(
[id] => 10684376
[patent_doc_number] => 20160030522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'COMBINATION THERAPY TO IMPROVE SOFT TISSUE HEALING, FAT GRAFT HEALING, ENDOCHONDRAL BONE HEALING AND OSTEOINTEGRATION'
[patent_app_type] => utility
[patent_app_number] => 14/776854
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9348
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776854
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776854 | COMBINATION THERAPY TO IMPROVE SOFT TISSUE HEALING, FAT GRAFT HEALING, ENDOCHONDRAL BONE HEALING AND OSTEOINTEGRATION | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10685855
[patent_doc_number] => 20160032001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'ANTI-RANKL ANTIBODIES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/776248
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 29892
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776248 | Anti-RANKL antibodies and methods of use | Mar 10, 2014 | Issued |
Array
(
[id] => 10662289
[patent_doc_number] => 20160008433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 14/772209
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22424
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772209
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772209 | Peptides and compositions for treatment of joint damage | Mar 6, 2014 | Issued |